PVLA · ISSUER CIK 1583648
PALVELLA THERAPEUTICS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 3 PALVELLA THERAPEUTICS, INC. insiders reported $0.00 of open-market purchases and $9.6M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 5 of 6 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$9.6MInsider selling
−$9.6MNet open-market
Oct 23, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 202616:05 | Oct 21, 2026 | PVLA | Chief Operating Officer | S · Sell10b5-1 | $124.58 | −4,313 | 0 | -100% | −$537K | ||
| Oct 23, 202616:05 | Oct 21, 2026 | PVLA | Chief Operating Officer | M · Exercise10b5-1 | $8.11 | +4,313 | 4,313 | New | $35K | ||
| Oct 14, 202619:14 | Oct 14, 2026from Oct 12, 2026 | PVLA | Director | S · Sell10b5-1 | $130.16 | −27,500 | 132,616 | -17% | −$3.6M | ||
| Sep 18, 202616:05 | Sep 16, 2026 | PVLA | Chief Operating Officer | S · Sell10b5-1 | $152.24 | −4,302 | 0 | -100% | −$655K | ||
| Sep 18, 202616:05 | Sep 16, 2026 | PVLA | Chief Operating Officer | M · Exercise10b5-1 | $8.11 | +4,302 | 4,302 | New | $35K | ||
| Sep 15, 202621:15 | Sep 15, 2026from Sep 11, 2026 | PVLA | Director | S · Sell10b5-1 | $151.53 | −27,500 | 160,116 | -15% | −$4.2M | ||
| Sep 4, 202616:05 | Sep 2, 2026 | PVLA | Director | S · Sell | $157.00 | −313 | 250 | -56% | −$49K | ||
| Sep 4, 202616:05 | Sep 2, 2026 | PVLA | Director | M · Exercise | $127.20 | +313 | 563 | +125% | $40K | ||
| Aug 20, 202616:05 | Aug 19, 2026 | PVLA | Chief Operating Officer | S · Sell10b5-1 | $152.21 | −4,302 | 0 | -100% | −$655K | ||
| Aug 20, 202616:05 | Aug 19, 2026 | PVLA | Chief Operating Officer | M · Exercise10b5-1 | $8.11 | +4,302 | 4,302 | New | $35K |